Australia Stock Exchange release from AVITA MED CDI : AVITA Medical Completes Enrollment in Vitiligo Pivotal Trial
15/12/2021 23:10
Australia Stock Exchange release from AVITA MED CDI AVH.AX : AVITA Medical Completes Enrollment in Vitiligo Pivotal Trial
Recent news on AVITA Medical
See all newsASX-listed Avita Medical rises as data shows efficiency of its medical device
Australia-listed shares of AVITA Medical slump on forecast cut
AVITA Medical's shares sink 19% after another forecast cut
Avita Medical Inc Reports Results For The Quarter Ended In January: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 54 Cents A Share: Earnings Preview